2025 UHMS Mid-West Chapter Town Hall on Clinical Hyperbaric Medicine Enduring Material
Tracking # 20-1323295
$99999.00
There are no ratings for this course
Learn moreCourse overview
Learner Objectives: 1.The Mid-West Chapter was re-formed to bring together thoughts and issues throughout the multi-state area regarding clinical application to hyperbaric medicine practice. To provide up to date educational offerings, as well as new information related to hyperbaric medicine, and develop a closer relationship with Undersea & Hyperbaric Medical Society. Objectives: Understand the current knowledge regarding the pathophysiology of avascular necrosis (AVN) of the femoral head and condyles. 2. Describe the proposed mechanisms of hyperbaric oxygen therapy and available treatments for AVN of the femoral head and condyles. 3. Describe the goals and selection of treatment based on stage of AVN of the femoral head and condyles. 4. Understand the rationale for using hyperbaric oxygen for inflammatory bowel disease and be presented the results of research on the use of hyperbaric oxygen with patients having inflammatory bowel disease. 5. The attendee will be able to describe briefly 3 varieties of targeted radiation therapy. 6. The attendee will be able to describe the usual dosing scheme for a course of radiation intended to be curative. 7. The attendee will be able to describe image-guided radiation. 8. Review steps to plan for UHMS accreditation. 9. Review how to incorporate utilization review of cases. 10. Review how to integrate peer review for audits of hyperbaric medicine treatments Subject Matter: Fellow Cases, Aseptic Necrosis of the Femoral Head and of Other Bones: commonly described as AVN, Inflammatory Bowel, Critical Care in a Monoplace Chamber, A Primer in Radiation Therapy for the Hyperbaric Community, PANEL: Building a Successful and Sustainable Program, Q/A Panel: Ask the Experts. Teaching Methods: Recorded Lectures, Panels, Question & Answer. Evaluation Methods: Evaluation is offered at the end of the program through the UHMS website, which evaluates the effectiveness of the meeting, speakers and that no bias was presented, and overall objectives were met.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Florida Board of Nursing - Certified Nursing Assistants
Certified Nursing Assistant
Florida Board of Respiratory Care
Certified Respiratory Therapist
Registered Respiratory Therapist
Respiratory Care Practitioner Critical Care
Respiratory Care Practitioner Non-Critical Care
Disclosure statements
Full Disclosure Statement: All faculty members and planners participating in continuing medical education activities sponsored by Undersea and Hyperbaric Medical Society are expected to disclose to the participants any relevant financial relationships with ineligible companies. Full disclosure of faculty and planner relevant financial relationships will be made at the activity.
Disclosures: All individuals in control of content for this educational activity with their relevant financial relationship disclosed are listed below (if applicable). An individual who refuses to disclose relevant financial relationships will be disqualified from being in control of educational content at any time, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity.
Financial relationships are relevant if the following three conditions are met for the individual who will control content of the education:
- A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
- The content of the education is related to the products of an ineligible company with whom the person has a financial relationship.
- The financial relationship existed during the past 24 months
“None of the individuals in control of content (planners/faculty/reviewers/authors) for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”